Log in
Enquire now
Alentis Therapeutics

Alentis Therapeutics

Alentis Therapeutics is a monoclonal Antibody.

OverviewStructured DataIssuesContributors

Contents

alentis.ch
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biomedical engineering
Biomedical engineering
Liver disease
Liver disease
Endocrine disease
Endocrine disease
Engineering
Engineering
Biotechnology
Biotechnology
Location
Switzerland
Switzerland
Pitchbook URL
pitchbook.com/profiles...267157-99
Email Address
info@alentis.ch
Investors
BioMedPartners
BioMedPartners
0
Jeito Capital
Jeito Capital
Total Funding Amount (USD)
79,500,000
Latest Funding Round Date
September 16, 2021
Latest Funding Type
Series B
Series B
Country
Switzerland
Switzerland

Other attributes

Company Operating Status
Active
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Alentis Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.